what are the risks of glp 1 How Do You Know When Semaglutide GLP-1 Is Working? Part 2 of a 3-Part

I am now on a low dose of Mounjaro for my PCOS as well as working out. Gracie first shared her PCOS struggles in March 2022

This is critical because droplet size determines where in the nasal cavity the drug deposits: droplets in the appropriate size range (typically 30200 m for nasal sprays) deposit in the nasal turbinates, where absorption occurs, while excessively small droplets may penetrate to the lower respiratory tract, and excessively large droplets may not clear the nasal vestibule

Clinical trials of tirzepatide, a dual GLP-1 and glucose-dependent insulinotropic peptide (GIP) receptor agonist, reported constipation in approximately 2527% of participants at therapeutic doses

Metabolic function: Insulin resistance dropped by 64% and fasting insulin fell by 65%, indicating substantially improved blood sugar control

or Canada, so its sold through a gray market labeling loophole